201 related articles for article (PubMed ID: 32892552)
21. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
[TBL] [Abstract][Full Text] [Related]
23. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.
Li L; Yang X; Ji W; Zhu Q; Yang X; Niu J; Li W
BMC Gastroenterol; 2023 May; 23(1):142. PubMed ID: 37161409
[TBL] [Abstract][Full Text] [Related]
24. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
25. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
Virchows Arch; 2019 Mar; 474(3):315-324. PubMed ID: 30554333
[TBL] [Abstract][Full Text] [Related]
26. Gastric Adenocarcinoma with Enteroblastic Differentiation Resected through Endoscopic Submucosal Dissection: A Case Report.
Ishikawa A; Nakamura K
Case Rep Gastroenterol; 2024; 18(1):68-73. PubMed ID: 38333765
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
[TBL] [Abstract][Full Text] [Related]
28. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
[TBL] [Abstract][Full Text] [Related]
29. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
30. Fetal gut-like differentiation in gallbladder cancer.
Koyama K; Maeda D; Tamura D; Narita C; Kudo-Asabe Y; Sato T; Yamamoto Y; Sageshima M; Nanjo H; Goto A
Hum Pathol; 2017 Dec; 70():27-34. PubMed ID: 28970139
[TBL] [Abstract][Full Text] [Related]
31. Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation.
Yamashiro Y; Saito T; Hayashi T; Murakami T; Yanai Y; Tsuyama S; Suehara Y; Takamochi K; Yao T
Histopathology; 2020 Sep; 77(3):492-502. PubMed ID: 32438490
[TBL] [Abstract][Full Text] [Related]
32. [Two cases of gastric cancer expressing Glypican 3, but producing AFP with different lectin affinity].
Oishi C; Baba T; Kubota Y; Shimotsuma Y; Kitamura K; Honma T; Ikegami A; Inokuchi M; Umeda T; Yoshida H; Imawari M
Nihon Shokakibyo Gakkai Zasshi; 2009 Jun; 106(6):805-12. PubMed ID: 19498312
[TBL] [Abstract][Full Text] [Related]
33. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma.
Chen J; Röcken C; Treiber G; Jentsch-Ulrich K; Malfertheiner P; Ebert MP
Dig Dis; 2003; 21(4):357-62. PubMed ID: 14752227
[TBL] [Abstract][Full Text] [Related]
35. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.
Matsunou H; Konishi F; Jalal RE; Yamamichi N; Mukawa A
Cancer; 1994 Feb; 73(3):534-40. PubMed ID: 7507794
[TBL] [Abstract][Full Text] [Related]
36. Alpha-Fetoprotein (AFP)-Negative Hepatoid Adenocarcinoma of the Stomach and its Associated Uncommon Features With a Review.
Rajasekaran P; Pattnaik B; Mishra M; Shahin M; Mishra P; Ayyanar P
Int J Surg Pathol; 2023 Aug; 31(5):872-878. PubMed ID: 36503302
[TBL] [Abstract][Full Text] [Related]
37. Esophageal adenocarcinoma with enteroblastic differentiation arising in ectopic gastric mucosa in the cervical esophagus: a case report and literature review.
Gushima R; Narita R; Shono T; Naoe H; Yao T; Sasaki Y
J Gastrointestin Liver Dis; 2017 Jun; 26(2):193-197. PubMed ID: 28617891
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic features and prognosis of 51 patients with α-fetoprotein-producing gastric cancer].
Liu X; Yang M; Gao J; Zhang S; Xi Y
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):231-4. PubMed ID: 25975796
[TBL] [Abstract][Full Text] [Related]
39. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
Chen Y; Qu H; Jian M; Sun G; He Q
Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
[TBL] [Abstract][Full Text] [Related]
40. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Wang YK; Shen L; Jiao X; Zhang XT
World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]